Published in

Springer Nature [academic journals on nature.com], Leukemia, 3(32), p. 788-800, 2017

DOI: 10.1038/leu.2017.276

Links

Tools

Export citation

Search in Google Scholar

Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia

Journal article published in 2017 by S. Degryse, C. E. de Bock ORCID, S. Demeyer, I. Govaerts, S. Bornschein, D. Verbeke, K. Jacobs, S. Binos, D. A. Skerrett-Byrne, H. C. Murray, N. M. Verrills, P. Van Vlierberghe ORCID, J. Cools, M. D. Dun
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO